321 related articles for article (PubMed ID: 17891368)
21. The histone deacetylase inhibitor vorinostat induces calreticulin exposure in childhood brain tumour cells in vitro.
Sonnemann J; Gressmann S; Becker S; Wittig S; Schmudde M; Beck JF
Cancer Chemother Pharmacol; 2010 Aug; 66(3):611-6. PubMed ID: 20221600
[TBL] [Abstract][Full Text] [Related]
22. Molecular characteristics of immunogenic cancer cell death.
Tesniere A; Panaretakis T; Kepp O; Apetoh L; Ghiringhelli F; Zitvogel L; Kroemer G
Cell Death Differ; 2008 Jan; 15(1):3-12. PubMed ID: 18007663
[TBL] [Abstract][Full Text] [Related]
23. Disruption of the PP1/GADD34 complex induces calreticulin exposure.
Kepp O; Galluzzi L; Giordanetto F; Tesniere A; Vitale I; Martins I; Schlemmer F; Adjemian S; Zitvogel L; Kroemer G
Cell Cycle; 2009 Dec; 8(23):3971-7. PubMed ID: 19901557
[TBL] [Abstract][Full Text] [Related]
24. Reduction of endoplasmic reticulum Ca2+ levels favors plasma membrane surface exposure of calreticulin.
Tufi R; Panaretakis T; Bianchi K; Criollo A; Fazi B; Di Sano F; Tesniere A; Kepp O; Paterlini-Brechot P; Zitvogel L; Piacentini M; Szabadkai G; Kroemer G
Cell Death Differ; 2008 Feb; 15(2):274-82. PubMed ID: 18034188
[TBL] [Abstract][Full Text] [Related]
25. Immunogenic cell death modalities and their impact on cancer treatment.
Kepp O; Tesniere A; Schlemmer F; Michaud M; Senovilla L; Zitvogel L; Kroemer G
Apoptosis; 2009 Apr; 14(4):364-75. PubMed ID: 19145485
[TBL] [Abstract][Full Text] [Related]
26. iNOS activity is necessary for the cytotoxic and immunogenic effects of doxorubicin in human colon cancer cells.
De Boo S; Kopecka J; Brusa D; Gazzano E; Matera L; Ghigo D; Bosia A; Riganti C
Mol Cancer; 2009 Nov; 8():108. PubMed ID: 19925669
[TBL] [Abstract][Full Text] [Related]
27. The key role of calreticulin in immunomodulation induced by chemotherapeutic agents.
Yamamura Y; Tsuchikawa T; Miyauchi K; Takeuchi S; Wada M; Kuwatani T; Kyogoku N; Kuroda A; Maki T; Shichinohe T; Hirano S
Int J Clin Oncol; 2015 Apr; 20(2):386-94. PubMed ID: 24972573
[TBL] [Abstract][Full Text] [Related]
28. Viral subversion of immunogenic cell death.
Kepp O; Senovilla L; Galluzzi L; Panaretakis T; Tesniere A; Schlemmer F; Madeo F; Zitvogel L; Kroemer G
Cell Cycle; 2009 Mar; 8(6):860-9. PubMed ID: 19221507
[TBL] [Abstract][Full Text] [Related]
29. Molecular determinants of immunogenic cell death elicited by anticancer chemotherapy.
Kepp O; Galluzzi L; Martins I; Schlemmer F; Adjemian S; Michaud M; Sukkurwala AQ; Menger L; Zitvogel L; Kroemer G
Cancer Metastasis Rev; 2011 Mar; 30(1):61-9. PubMed ID: 21249425
[TBL] [Abstract][Full Text] [Related]
30. Lysyl tRNA synthetase is required for the translocation of calreticulin to the cell surface in immunogenic death.
Kepp O; Gdoura A; Martins I; Panaretakis T; Schlemmer F; Tesniere A; Fimia GM; Ciccosanti F; Burgevin A; Piacentini M; Eggleton P; Young PJ; Zitvogel L; van Endert P; Kroemer G
Cell Cycle; 2010 Aug; 9(15):3072-7. PubMed ID: 20699648
[TBL] [Abstract][Full Text] [Related]
31. Calreticulin requires an ancillary adjuvant for the induction of efficient cytotoxic T cell responses.
Bak SP; Amiel E; Walters JJ; Berwin B
Mol Immunol; 2008 Mar; 45(5):1414-23. PubMed ID: 17936359
[TBL] [Abstract][Full Text] [Related]
32. [Antitumoral immunization during cancer chemotherapy].
Zitvogel L; Hannani D; Aymeric L; Kepp O; Martins I; Kroemer G
Bull Acad Natl Med; 2012 Jun; 196(6):1075-86. PubMed ID: 23596856
[TBL] [Abstract][Full Text] [Related]
33. Tumor cell lysates as immunogenic sources for cancer vaccine design.
González FE; Gleisner A; Falcón-Beas F; Osorio F; López MN; Salazar-Onfray F
Hum Vaccin Immunother; 2014; 10(11):3261-9. PubMed ID: 25625929
[TBL] [Abstract][Full Text] [Related]
34. Immune-system-dependent anti-tumor activity of a plant-derived polyphenol rich fraction in a melanoma mouse model.
Gomez-Cadena A; Urueña C; Prieto K; Martinez-Usatorre A; Donda A; Barreto A; Romero P; Fiorentino S
Cell Death Dis; 2016 Jun; 7(6):e2243. PubMed ID: 27253407
[TBL] [Abstract][Full Text] [Related]
35. Immunogenic calreticulin exposure occurs through a phylogenetically conserved stress pathway involving the chemokine CXCL8.
Sukkurwala AQ; Martins I; Wang Y; Schlemmer F; Ruckenstuhl C; Durchschlag M; Michaud M; Senovilla L; Sistigu A; Ma Y; Vacchelli E; Sulpice E; Gidrol X; Zitvogel L; Madeo F; Galluzzi L; Kepp O; Kroemer G
Cell Death Differ; 2014 Jan; 21(1):59-68. PubMed ID: 23787997
[TBL] [Abstract][Full Text] [Related]
36. Immunogenic death of colon cancer cells treated with oxaliplatin.
Tesniere A; Schlemmer F; Boige V; Kepp O; Martins I; Ghiringhelli F; Aymeric L; Michaud M; Apetoh L; Barault L; Mendiboure J; Pignon JP; Jooste V; van Endert P; Ducreux M; Zitvogel L; Piard F; Kroemer G
Oncogene; 2010 Jan; 29(4):482-91. PubMed ID: 19881547
[TBL] [Abstract][Full Text] [Related]
37. Combined Rho-kinase inhibition and immunogenic cell death triggers and propagates immunity against cancer.
Nam GH; Lee EJ; Kim YK; Hong Y; Choi Y; Ryu MJ; Woo J; Cho Y; Ahn DJ; Yang Y; Kwon IC; Park SY; Kim IS
Nat Commun; 2018 Jun; 9(1):2165. PubMed ID: 29867097
[TBL] [Abstract][Full Text] [Related]
38. Immunogenic chemotherapy: discovery of a critical protein through proteomic analyses of tumor cells.
Apetoh L; Obeid M; Tesniere A; Ghiringhelli F; Fimia GM; Piacentini M; Kroemer G; Zitvogel L
Cancer Genomics Proteomics; 2007; 4(2):65-70. PubMed ID: 17804868
[TBL] [Abstract][Full Text] [Related]
39. High hydrostatic pressure induces immunogenic cell death in human tumor cells.
Fucikova J; Moserova I; Truxova I; Hermanova I; Vancurova I; Partlova S; Fialova A; Sojka L; Cartron PF; Houska M; Rob L; Bartunkova J; Spisek R
Int J Cancer; 2014 Sep; 135(5):1165-77. PubMed ID: 24500981
[TBL] [Abstract][Full Text] [Related]
40. Radiation induces an antitumour immune response to mouse melanoma.
Perez CA; Fu A; Onishko H; Hallahan DE; Geng L
Int J Radiat Biol; 2009 Dec; 85(12):1126-36. PubMed ID: 19995238
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
